- You must enroll in this course to access course content.
ADHD Medications in Pregnancy & Breastfeeding
A practical, evidence-based course for clinicians making real-world ADHD pharmacotherapy decisions during pregnancy, delivery, and lactation. Five drug classes. Two clinical contexts. One decision framework.
How to Use This Course
Three layers of clinical depth — read by the layer that fits your moment.
Every chapter is built to be used three ways: a 60-second bottom-line read for point-of-care decisions, a structured decision algorithm and clinic-ready toolkit for workflow integration, and a full evidence section for complex cases that need the underlying PK data, FDA/LactMed label language, and special-population considerations.
Each drug class is covered in its own chapter — dextroamphetamine, methylphenidate, alpha-2 adrenergic agonists, atomoxetine, and viloxazine — followed by a cross-class synthesis chapter that integrates everything into a single decision framework. The breastfeeding section mirrors this structure, with each chapter focused on lactation pharmacokinetics, infant safety, and milk-supply considerations.
Chapter Anatomy
Each chapter follows a structured framework for rapid clinical decision-making.
- Executive Summary & the 60-Second Read — FDA label disclosure, key teratogenicity signal, dose considerations, expert consensus.
- Formulations & Class Comparison — IR vs. ER, prodrug considerations, single-isomer vs. mixed salts, within-class trade-offs.
- Pharmacokinetics & Placental Transfer — maternal PK changes by trimester, placental transfer ratios, fetal exposure estimates.
- FDA Label & Verbatim Regulatory Language — exact pregnancy language, animal reproductive toxicity, post-PLLR interpretation.
- Teratogenicity, Obstetric & Neonatal Outcomes — malformation risk, preeclampsia/SGA/preterm signals, NAS, largest cohorts.
- Clinical Decision Algorithm & "Safe-Use" Protocol — continue/switch/discontinue tree, dose optimization, monitoring schedule.
- Drug Interactions & Anesthesia Considerations — antacid/PPI, halogenated agents, neuraxial, CYP2D6, CYP1A2.
- Special Populations & Red Flags — SUD history, cardiac comorbidity, comorbid mood/anxiety, stop criteria.
- Clinical Pearls, FAQ, EMR Templates & Patient Scripts — ready-to-paste shared-decision-making language.
- Executive Summary & the 60-Second Read — LactMed verdict, Relative Infant Dose at a glance, infant-safety bottom line.
- Formulations & Class Comparison — how formulation and half-life shape milk transfer and the timing of feeds.
- Lactation Pharmacokinetics & Milk Transfer — Relative Infant Dose (RID), milk-to-plasma ratio, Tmax/feed timing, measured infant serum levels.
- FDA Label & LactMed Review — verbatim lactation labeling, including post-2019 Clinical Lactation Study data where available.
- Infant Safety & Reported Outcomes — adverse-event signals, growth, sedation/irritability, what to monitor.
- Milk-Supply Considerations — dopaminergic effects on prolactin and supply, and how to counsel.
- Clinical Decision Algorithm & "Safe-Use" Protocol — continue/switch/time-the-feed, dose optimization, infant monitoring.
- Drug Interactions & Special Populations — comedications, the preterm/NICU infant, low supply, tandem nursing.
- Clinical Pearls, FAQ, EMR Templates & Patient Scripts — ready-to-paste lactation counseling language.
The Breastfeeding Section Is Live
Six chapters covering ADHD pharmacotherapy during lactation — with measured human-milk PK data, FDA label and LactMed review, infant-outcome evidence, and a unified decision framework for the breastfeeding mother on ADHD treatment. Includes the landmark Yamada 2025 atomoxetine study (the lowest measured Relative Infant Dose of any ADHD medication) and the January 2025 Qelbree (viloxazine) label update — the first ADHD treatment to fulfill the FDA's 2019 Clinical Lactation Studies post-marketing requirement.
- Dextroamphetamine & Breastfeeding Free Preview
- Methylphenidate & Breastfeeding
- Alpha-2 Adrenergic Agonists & Breastfeeding
- Atomoxetine & Breastfeeding
- Viloxazine & Breastfeeding
- Cross-Class Synthesis — Clinical Decision-Making
Move from clinical uncertainty to confident, evidence-based ADHD pharmacotherapy decisions during pregnancy and breastfeeding — in minutes, not hours.
Try a Chapter Free
No membership required · full chapter access.
Part of the Academy
Academy Membership includes this entire course — both the Pregnancy and Breastfeeding sections — plus the full perinatal psychopharmacology library (antidepressants, antipsychotics, mood stabilizers, ADHD) and every new course as it launches. Cancel anytime.
Responses